Drug Database
Back to search

United States· US:0169-3687_f474a2c6-c2fe-4dec-86a9-7fc2aef980f3

Levemir

A insulin detemir product containing insulin detemir, registered in United States by Novo Nordisk. The same ATC class is registered in 14 of our 19 countries.

ATC A10AE05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLevemirATCA10AE05REGISTER NO.US:0169-3687_f474a2c6…PACKS LISTED2CHECKEDAugust 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insulin detemirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin detemir is registered in 14 of 19 countries.

Countries holding a registration under ATC A10AE05 (insulin detemir), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search insulin detemir products by name

Insulin detemir · ATC A10AE05

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
INSULIN DETEMIR
Manufacturer
Novo Nordisk
Country
United States (US)
ATC code
A10AE05
ATC class
Insulin detemir
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 30, 2026

Packs & prices · 2

  • ndc11
    0169368712
    1 VIAL, GLASS in 1 CARTON (0169-3687-12) / 10 mL in 1 VIAL, GLASS
  • ndc11
    0169-3687-12

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

434 interactions on record for insulin detemir.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check insulin detemir against other medicinesHow interaction checks work

Insulin detemir · interactions on record

434 records

  • 15 severe
  • 368 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Insulin detemir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin detemir products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Levemir Flexpen, Levemir Flextouch
  • Norway · Levemir Flexpen, Levemir Flextouch

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb84f964-b222-4895-8959-2ca617df1311
GET /v1/drugs/bb84f964-b222-4895-8959-2ca617df1311?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "100",
  "substance": "INSULIN DETEMIR",
  "productndc": "0169-3687",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "[iU]/mL",
  "application_number": "BLA021536",
  "marketing_category": "BLA"
}
API referenceMCP serverPlans

See everything about insulin detemir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console